PMA device
PERIMOUNT Magna Mitral Ease Pericardial Bioprosthesis
Edwards Lifesciences, LLC · Replacement Heart-Valve (DYE, Class III) · First FDA decision Apr 10, 2025, newest Apr 10, 2025Aortic stenosisMitral regurgitation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
6
Naming "PERIMOUNT Magna"
MAUDE reports
14,808
Brand "PERIMOUNT Magna", since 2015
PubMed studies
145
Mentioning "PERIMOUNT Magna"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing PERIMOUNT Magna Mitral Ease Pericardial Bioprosthesis
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- PERIMOUNT Magna Mitral Ease Pericardial BioprosthesisPMA supplement
P860057-S220 · Decided Apr 10, 2025 · 161 days after receipt · Normal 180 Day Track No User Fee
Device type: replacement Heart-valve (DYE) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "PERIMOUNT Magna", any status and sponsor, newest update first.
Edwards LifesciencesPublic (EW)
NCT00853632 · 329 participants · Start Aug 2007 · Primary completion Mar 6, 2024
Device: CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES · For: Coronary Artery Disease; Mitral Valve Regurgitation; Mitral Valve Incompetence and 1 more
Sites: Sacramento, California; Orlando, Florida; Chicago, Illinois · 15 sites in all
- Comparison of Two Pericardial Bioprostheses in AVRPivotal-lookingCompleted
Seoul National University HospitalAcademic, hospital or other
NCT03796442 · 140 participants · Start Jan 23, 2019 · Primary completion May 13, 2021
Device: AVR with AVALUS; AVR with CEPME · For: Aortic Valve Disease
Sites: Seongnam, South Korea; Seoul, South Korea
University of PadovaAcademic, hospital or other
NCT03843320 · 340 participants (planned) · Start Dec 2021 · Primary completion Dec 2023
Device: SAPIEN 3; SAPIEN XT and 3 more · For: Aortic Valve Stenosis
Sites: Padova, Italy; Vicenza, Italy
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "PERIMOUNT Magna", and for the whole product code for context.
This brand
14,808 reports: 320 malfunction, 14,353 injury, 124 death
Whole product code DYE
30,601 reports: 1,137 malfunction, 29,078 injury, 359 death
Newest reports for this brand
2015691-2026-19865 · Received Oct 30, 2026 · Event dated Sep 16, 2026
Device type: Replacement Heart-Valve (DYE)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Insufficient Information
2015691-2026-19794 · Received Oct 28, 2026 · Event dated Jun 1, 2024
Device type: Replacement Heart-Valve (DYE)
Device problem as coded: Degraded
Patient problem as coded: Heart Failure/Congestive Heart Failure
2015691-2026-19801 · Received Oct 28, 2026 · Event dated Jul 16, 2026
Device type: Replacement Heart-Valve (DYE)
Device problem as coded: Perivalvular Leak
Patient problem as coded: Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "PERIMOUNT Magna"[tiab]. The summary above synthesizes these.
- Trifecta versus Perimount Magna Ease aortic valves: Failure mechanisms.
Suzuki R, Ito T, Suzuki M, et al. · Asian Cardiovasc Thorac Ann · 2022
- Structural valve degeneration of bioprosthetic aortic valves: A network meta-analysis.
Squiers JJ, Robinson NB, Audisio K, et al. · J Thorac Cardiovasc Surg · 2023Research Support, Non-U.S. Gov't, Network Meta-Analysis
- Perimount MAGNA Ease vs. INSPIRIS Resilia Valve: A PS-Matched Analysis of the Hemodynamic Performances in Patients below 70 Years of Age.
Francica A, Tonelli F, Rossetti C, et al. · J Clin Med · 2023
- Durability of a bovine pericardial aortic bioprosthesis based on Valve Academic Research Consortium-3 echocardiographic criteria.
Kermen S, Strella J, Aupart A, et al. · JTCVS Open · 2022
- The Mitris RESILIA Valve: New Skin for a Proven Design.
Ciccarelli G, Weltert L, Scaffa R, et al. · Surg Technol Int · 2024
- Adaptation of Aortic Bioprosthetic Valves for Pulmonary Position: Comparative Analysis of Transcatheter and Surgical Valves.
Shafiei M, Qiu D, Azadani AN · J Cardiovasc Transl Res · 2024Comparative Study, Research Support, Non-U.S. Gov't
- Left axillary approach for pulmonary valve replacement.
Gil-Jaurena JM, Pardo C, Pita A, et al. · Multimed Man Cardiothorac Surg · 2023Case Reports, Video-Audio Media
- Ten-year clinical and echocardiographic follow-up of third-generation biological prostheses in the aortic position.
Francica A, Benvegnù L, San Biagio L, et al. · J Thorac Cardiovasc Surg · 2024
- Trifecta Versus Perimount Magna Ease Aortic Valve Prostheses.
Biancari F, Valtola A, Juvonen T, et al. · Ann Thorac Surg · 2020Comparative Study, Multicenter Study
- A Non-Invasive Material Characterization Framework for Bioprosthetic Heart Valves.
Abbasi M, Barakat MS, Dvir D, et al. · Ann Biomed Eng · 2019
- Sutureless and Rapid Deployment Prosthesis in Redo-Bentall Endocarditis.
Nicolardi S, De Masi De Luca G, Mangia F, et al. · Case Rep Surg · 2024Case Reports
- Serial echocardiographic evaluation of the Perimount Magna Ease prosthesis.
Mayr B, Burri M, Vitanova K, et al. · J Thorac Dis · 2021
Other devices of this type
Also filed under product code DYE.
- Carpentier-Edwards PERIMOUNT Magna Pericardial Aortic BioprosthesesEdwards Lifesciences, LLC · PMA 2021
- Carpentier-Edwards Perimount Pericardial Aortic BioprosthesisEdwards Lifesciences, LLC · PMA 2013
- Edwards Prima Plus Stentless Porcine BioprosthesisEdwards Lifesciences, LLC · PMA 2013
- Mosaic Porcine BioprosthesisMedtronic, Inc. · PMA 2006
- Carpentier-Edwards Duraflex Low PressureEdwards Lifesciences, LLC · PMA 2013
- Hancock II Porcine BioprosthesisMedtronic, Inc. · PMA 2013
- Carpentier-Edwards Perimount Plus Pericardial BioprosthesisEdwards Lifesciences, LLC · PMA 2009
- Mosaic Neo Mitral BioprosthesisMedtronic, Inc. · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.